ClinConnect ClinConnect Logo
Search / Trial NCT02425540

Characterization of Ovarian Masses Unable to Classify With Gynecological Ultrasonography: Value of Pelvic MRI With Perfusion- and Diffusion-weighted Imaging

Launched by UNIVERSITAIRE ZIEKENHUIZEN KU LEUVEN · Apr 20, 2015

Trial Information

Current as of November 10, 2025

Recruiting

Keywords

Pelvic Mri

ClinConnect Summary

This clinical trial is looking at a special type of MRI scan to help doctors better understand ovarian masses that cannot be clearly identified with a standard ultrasound. If you are a woman with an ovarian mass that the ultrasound has not been able to classify, you might be eligible to participate in this study. The goal is to see if this advanced MRI technique, which includes special imaging methods called diffusion- and perfusion-weighted imaging, can provide clearer information about these uncertain masses.

If you join the trial, you will undergo a pelvic MRI scan that could help doctors make more informed decisions about your condition. It's important to know that this study is only for women with undetermined ovarian masses, so if your ultrasound has already provided a clear diagnosis, you would not qualify. Additionally, if you have any reasons that prevent you from having an MRI or if you decide not to participate, you can choose to withdraw at any time. The trial is currently recruiting participants, and your involvement could contribute to better understanding and treatment options for ovarian masses in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • \*Any woman with an adnexal mass undetermined by gynecological ultrasound
  • Exclusion Criteria:
  • Any lesion with definite diagnosis by gynecological ultrasound
  • Denial or withdrawal of oral informed consent.
  • Contra-indication for MRI

About Universitaire Ziekenhuizen Ku Leuven

Universitaire Ziekenhuizen KU Leuven is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. Affiliated with KU Leuven, one of Europe’s premier universities, the institution integrates cutting-edge scientific inquiry with high-quality patient care. It plays a pivotal role in the development and implementation of clinical trials, fostering collaboration between researchers, healthcare professionals, and industry partners to translate scientific discoveries into effective treatments. The hospital's multidisciplinary approach ensures comprehensive patient safety and ethical standards, positioning it as a trusted sponsor in the realm of clinical research.

Locations

Leuven, Vlaams Brabant, Belgium

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials